Live Breaking News & Updates on Brii bio

Stay informed with the latest breaking news from Brii bio on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Brii bio and stay connected to the pulse of your community

BRII-835 + BRII-179 for Chronic Hepatitis B in 7MM: Market Size, Forecast, and Emerging Insights 2019-2032

Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "BRII-835 + BRII-179 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."BRII-835 + BRII-179 Market Size, Forecast, and Emerging Insight - 2032" report provides comprehensive insights about BRII-835 + BRII-179 for chronic hepatitis B in the seven major markets and China. A detailed picture of the BRII-835 + BRII-179 for chronic hepatitis B in the 7MM, i.e., the United States, EU4 (Germany,

Germany , France , Japan , Italy , Taiwan , Hong-kong , Spain , China , Dublin , Ireland , United-states , United-kingdom

Brii punts HIV, depression, lung programs to potential partners

Brii punts HIV, depression, lung programs to potential partners
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

China , Chinese , Zhi-hong , Brii-biosciences , Qpex-biopharma , Brii-bio , Vir-biotechnology , Chinese-yuan ,

Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies

Acquiring all intellectual properties relating to BRII-179 and eliminating future milestone and royalty payments to VBI, subject to achievement of certain...

Hong-kong , Israel , Rehovot , Hamerkaz , United-states , Japan , Beijing , China , Macau , United-kingdom , Canada , Taiwan

VBI Vaccines (VBI) to Sell IP Rights for VBI-2601 to Brii Biosciences

VBI Vaccines (VBI) to Sell IP Rights for VBI-2601 to Brii Biosciences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , Brii-bio , Prehevbrio-prehevbri , Asia-pacific , Zhi-hong , Vaccines-inc , Nasdaq , Drug-administration , Brii-biosciences , Brii-biosciences-limited , Chief-executive-officer ,

VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences

CAMBRIDGE, Mass., February 14, 2024--VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI" or the "Company"), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced agreements whereby Brii Biosciences ("Brii Bio"), subject to certain activities, is expected to: (i) acquire the intellectual property for VBI-2601, VBI’s HBV immunotherapeutic development program, and eliminate payment obligations from the July 2023 agreements between VBI a

Japan , Canada , Rehovot , Hamerkaz , Israel , Massachusetts , United-states , Cambridge , Cambridgeshire , United-kingdom , Ottawa , Ontario

VBI Vaccines (VBIV) to Sell Manufacturing Capabilities, Certain Related Assets, Enters New License Agreement with Brii Biosciences

VBI Vaccines (VBIV) to Sell Manufacturing Capabilities, Certain Related Assets, Enters New License Agreement with Brii Biosciences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , Canada , Rehovot , Hamerkaz , Israel , Massachusetts , United-states , Cambridge , Cambridgeshire , United-kingdom , Ottawa , Ontario

VBI signs deal to sell manufacturing capabilities, certain assets with Brii Biosciences

VBI signs deal to sell manufacturing capabilities, certain assets with Brii Biosciences
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Israel , Japan , Rehovot , Hamerkaz , Brii-bio , Brii-biosciences , Asia-pacific ,

Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer

DURHAM, N.C., and BEIJING, Jan. 3, 2024 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company

Beijing , China , Shanghai , Thailand , Brian-alvin , Briana-johns , Zhi-hong , Brii-biosciences , Brii-bio , Brian-alvin-johns , Hemoshear-therapeutics-inc , Glaxosmithkline

VBI Vaccines Reports Third Quarter 2023 Financial Results

PreHevbrio global net revenue increased 52% quarter-over-quarter from Q2 to Q3 2023

Continued execution across earlier-stage pipeline, including:

Initiation of Phase 2b study of VBI-1901 in...

Wuhan , Hubei , China , Cambridge , Cambridgeshire , United-kingdom , United-states , Gilboa , Ha-afon , Israel , Rehovot , Hamerkaz

Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B

Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shanghai , China , Beijing , David-margolis , Brii-bio , Prnewswire-brii-biosciences-limited-bio , Brii-biosciences , Brii-biosciences-limited-bio , Biosciences-limited , Chief-medical-officer , Vir-biotechnology , Combination-study